5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.84▲ | 1.85▼ | 1.85▼ | 1.82▲ | 1.73▲ |
MA10 | 1.84▲ | 1.83▲ | 1.83▲ | 1.79▲ | 1.51▲ |
MA20 | 1.82▲ | 1.82▲ | 1.82▲ | 1.67▲ | 1.65▲ |
MA50 | 1.83▲ | 1.80▲ | 1.80▲ | 1.50▲ | 2.81▼ |
MA100 | 1.80▲ | 1.77▲ | 1.70▲ | 1.75▲ | 4.01▼ |
MA200 | 1.76▲ | 1.62▲ | 1.53▲ | 2.78▼ | 91.40▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.003▲ | 0.002▲ | 0.011▲ | 0.135▲ |
RSI | 53.369▲ | 53.412▲ | 54.188▲ | 62.663▲ | 46.300▼ |
STOCH | 48.179 | 59.716 | 71.405 | 67.443 | 41.436 |
WILL %R | -47.059 | -33.333 | -33.333 | -24.390▲ | -54.902 |
CCI | 48.019 | 63.395 | 77.778 | 86.467 | 133.629▲ |
▼ GAP | $GLMD Open Gap Down %2 | Set Alert |
Thursday, June 12, 2025 05:54 AM
Short interest in Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) decreased during the last reporting period, falling from 191.04K to 66.91K. This put 3.05% of the company's publicly available shares short.
|
Thursday, May 22, 2025 12:20 PM
GALMED PHARMACEUTICALS posted quarterly earnings results on Thursday, May 22nd.The company reported earnings of -$0.62 per share, beating estimates of -$0.91 by $0.29. The company also reported ...
|
Saturday, May 17, 2025 03:17 AM
Galmed Pharmaceuticals Ltd. company and executive profile by Barron's. View the latest GLMD company infomation and executive bios.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 1.825 | 1.88 | 1.81 | 1.84 | 224,438 |
27/06/25 | 1.76 | 1.87 | 1.75 | 1.81 | 112,663 |
26/06/25 | 1.76 | 1.83 | 1.75 | 1.79 | 235,633 |
25/06/25 | 1.90 | 1.94 | 1.80 | 1.81 | 373,659 |
24/06/25 | 1.82 | 1.85 | 1.75 | 1.85 | 419,300 |
23/06/25 | 1.86 | 1.88 | 1.6301 | 1.75 | 710,355 |
20/06/25 | 1.86 | 1.90 | 1.81 | 1.87 | 943,590 |
18/06/25 | 1.66 | 1.83 | 1.66 | 1.78 | 795,025 |
17/06/25 | 1.72 | 1.74 | 1.66 | 1.675 | 297,752 |
16/06/25 | 1.66 | 1.79 | 1.6208 | 1.725 | 845,212 |
|
|
||||
|
|
||||
|
|